Researchers use DNA origami to generate tiny mechanical devices that deliver a drug that cuts off the blood supply to tumors in mice.
December 15, 1986|
NEW YORK—Revlon has decided to end its support of a major university research effort into in vitro alternatives to the use of animals in product testing and research. Its action is the latest obstacle to progress in a field hampered by inadequate funding and differing approaches to the problem. The Laboratory for In Vitro Toxicologic Assay Development at The Rockefeller University was created six years ago by Revlon after intense pressure by animal rights activists to find an alternative